These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16469391)

  • 1. A shared neuroimmunological mechanism for drugs of addiction?
    Petitto JM
    J Neuroimmunol; 2006 Apr; 173(1-2):1-2. PubMed ID: 16469391
    [No Abstract]   [Full Text] [Related]  

  • 2. The neural substrates of drug addiction and dependence.
    Pulvirenti L; Koob GF
    Funct Neurol; 1990; 5(2):109-19. PubMed ID: 2172102
    [No Abstract]   [Full Text] [Related]  

  • 3. Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
    Toll L; Berzetei-Gurske IP; Polgar WE; Brandt SR; Adapa ID; Rodriguez L; Schwartz RW; Haggart D; O'Brien A; White A; Kennedy JM; Craymer K; Farrington L; Auh JS
    NIDA Res Monogr; 1998 Mar; 178():440-66. PubMed ID: 9686407
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic drugs and dopamine receptors.
    Strange PG
    Am J Psychiatry; 1991 Aug; 148(8):1101. PubMed ID: 1677238
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroendocrine markers of CNS drug effects.
    Johnstone EC; Ferrier IN
    Br J Clin Pharmacol; 1980 Jul; 10(1):5-21. PubMed ID: 6104974
    [No Abstract]   [Full Text] [Related]  

  • 6. Addiction: brain mechanisms and their treatment implications.
    Nutt DJ
    Lancet; 1996 Jan; 347(8993):31-6. PubMed ID: 8531549
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progress in studies on the mechanism of substance addiction in central nervous system].
    Zhang L; Zhou H; Tang Y; Liu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Jun; 18(2):296-8. PubMed ID: 11450558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid-dopamine interactions: implications for substance use disorders and their treatment.
    Volkow ND
    Biol Psychiatry; 2010 Oct; 68(8):685-6. PubMed ID: 20888455
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurotransmitter and neuroendocrine abnormalities associated with cocaine use.
    Dackis C; Gold MS
    Psychiatr Med; 1985; 3(4):461-83. PubMed ID: 2829287
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.
    López-Moreno JA; González-Cuevas G; Moreno G; Navarro M
    Addict Biol; 2008 Jun; 13(2):160-87. PubMed ID: 18422831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
    Cunha-Oliveira T; Rego AC; Oliveira CR
    Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the endogenous cannabinoid system in drug addiction.
    Parolaro D; Rubino T
    Drug News Perspect; 2008 Apr; 21(3):149-57. PubMed ID: 18560613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain lesions and psychostimulant drugs.
    Rech RH
    Psychopharmacol Bull; 1978 Oct; 14(4):35-8. PubMed ID: 704756
    [No Abstract]   [Full Text] [Related]  

  • 15. Divergent anatomical pattern of D1 and D3 binding and dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa mRNA expression in the Roman rat strains: Implications for drug addiction.
    Guitart-Masip M; Johansson B; Fernández-Teruel A; Cañete T; Tobeña A; Terenius L; Giménez-Llort L
    Neuroscience; 2006 Nov; 142(4):1231-43. PubMed ID: 17008016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of dopamine receptors and drug addiction: a comprehensive review.
    Le Foll B; Gallo A; Le Strat Y; Lu L; Gorwood P
    Behav Pharmacol; 2009 Feb; 20(1):1-17. PubMed ID: 19179847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis.
    Koob GF
    Addiction; 2006 Sep; 101 Suppl 1():23-30. PubMed ID: 16930158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circuits, drugs, and drug addiction.
    Koob GF
    Adv Pharmacol; 1998; 42():978-82. PubMed ID: 9328061
    [No Abstract]   [Full Text] [Related]  

  • 19. Substance addiction treatable, says new report.
    Bull World Health Organ; 2004 Apr; 82(4):318. PubMed ID: 15309818
    [No Abstract]   [Full Text] [Related]  

  • 20. Synaptic plasticity and addiction.
    Kauer JA; Malenka RC
    Nat Rev Neurosci; 2007 Nov; 8(11):844-58. PubMed ID: 17948030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.